Larry Todd Edwards Arcutis Biotherapeutics, Inc. (ARQT) insider trading activity

ARQT Quotes by TradingView

Larry Todd Edwards is SVP Chief Commercial Officer of Arcutis Biotherapeutics, Inc.. Currently has a direct ownership of 140,360 shares of ARQT, which is worth approximately $1.31 Million. The most recent transaction as insider was on May 17, 2024, when has been sold 7,640 shares (Common Stock) at a price of $8.98 per share, resulting in proceeds of $68,607. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 140K
59.5% 3M change
n/a 12M change
Total Value Held $1.31 Million

Larry Todd Edwards Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 17 2024
SELL
Open market or private sale
$68,607 $8.98 p/Share
7,640 Reduced 5.16%
140,360 Common Stock
May 16 2024
BUY
Grant, award, or other acquisition
-
60,000 Added 28.85%
148,000 Common Stock
Jan 12 2024
BUY
Grant, award, or other acquisition
-
28,000 Added 24.14%
88,000 Common Stock
Sep 27 2023
BUY
Grant, award, or other acquisition
-
60,000 Added 50.0%
60,000 Common Stock
LTE

Larry Todd Edwards

SVP Chief Commercial Officer
Westlake Village, CA

Track Institutional and Insider Activities on ARQT

Follow Arcutis Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARQT shares.

Notify only if

Insider Trading

Get notified when an Arcutis Biotherapeutics, Inc. insider buys or sells ARQT shares.

Notify only if

News

Receive news related to Arcutis Biotherapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ARQT